These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15120315)

  • 21. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
    Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz JC
    J Med Chem; 1992 Jun; 35(12):2231-8. PubMed ID: 1613748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles.
    Mor M; Bordi F; Silva C; Rivara S; Crivori P; Plazzi PV; Ballabeni V; Caretta A; Barocelli E; Impicciatore M; Carrupt PA; Testa B
    J Med Chem; 1997 Aug; 40(16):2571-8. PubMed ID: 9258364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles.
    De Esch IJ; Gaffar A; Menge WM; Timmerman H
    Bioorg Med Chem; 1999 Dec; 7(12):3003-9. PubMed ID: 10658607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups.
    Mor M; Bordi F; Silva C; Rivara S; Zuliani V; Vacondio F; Morini G; Barocelli E; Ballabeni V; Impicciatore M; Plazzi PV
    Farmaco; 2000 Jan; 55(1):27-34. PubMed ID: 10755228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonists.
    Linney ID; Buck IM; Harper EA; Kalindjian SB; Pether MJ; Shankley NP; Watt GF; Wright PT
    J Med Chem; 2000 Jun; 43(12):2362-70. PubMed ID: 10882362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
    Krause M; Ligneau X; Stark H; Garbarg M; Schwartz JC; Schunack W
    J Med Chem; 1998 Oct; 41(21):4171-6. PubMed ID: 9767653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and histamine H2-receptor activity of heterocyclic impromidine analogues.
    Buschauer A; Lachenmayr F; Schunack W
    Pharmazie; 1992 Feb; 47(2):86-91. PubMed ID: 1353262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
    Meier G; Krause M; Hüls A; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2004 May; 47(10):2678-87. PubMed ID: 15115409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.
    Grassmann S; Sadek B; Ligneau X; Elz S; Ganellin CR; Arrang JM; Schwartz JC; Stark H; Schunack W
    Eur J Pharm Sci; 2002 May; 15(4):367-78. PubMed ID: 11988398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: Preliminary pharmacological investigation.
    Barocelli E; Ballabeni V; Manenti V; Flammini L; Bertoni S; Morini G; Comini M; Impicciatore M
    Pharmacol Res; 2006 Mar; 53(3):226-32. PubMed ID: 16364652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.
    Walczyński K; Zuiderveld OP; Timmerman H
    Eur J Med Chem; 2005 Jan; 40(1):15-23. PubMed ID: 15642406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: the design of potent histamine H3 receptor antagonists.
    Tozer MJ; Buck IM; Cooke T; Kalindjian SB; McDonald IM; Pether MJ; Steel KI
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3103-8. PubMed ID: 10560733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and histamine H2-agonistic activity of ring-substituted phenyl analogues of impromidine.
    Buschauer A; Lachenmayr F; Schunack W
    Pharmazie; 1991 Dec; 46(12):840-5. PubMed ID: 1687832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
    Esbenshade TA; Fox GB; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan L; Wetter J; Marsh K; Bennani YL; Cowart MD; Sullivan JP; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):165-75. PubMed ID: 15608078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
    Mikó T; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    Bioorg Med Chem; 2004 May; 12(10):2727-36. PubMed ID: 15110854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro characterization of potency, affinity and selectivity of H3-antagonists: from thioperamide to thioperamide unrelated imidazole derivatives.
    Barocelli E; Ballabeni V; Caretta A; Bertoni S; Bordi F; Rivara S; Silva C; Mor M; Impicciatore M
    Farmaco; 1997; 52(6-7):463-9. PubMed ID: 9372599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M2 and M3 receptors.
    Griffin MT; Matsui M; Shehnaz D; Ansari KZ; Taketo MM; Manabe T; Ehlert FJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):339-49. PubMed ID: 14563784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
    Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
    Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles.
    Eriks JC; van der Goot H; Sterk GJ; Timmerman H
    J Med Chem; 1992 Aug; 35(17):3239-46. PubMed ID: 1507209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.